Tilray Inc (NASDAQ:TLRY - Get Free Report) shares dropped 5.6% during mid-day trading on Friday . The stock traded as low as $0.47 and last traded at $0.48. Approximately 8,427,173 shares were traded during trading, a decline of 71% from the average daily volume of 29,487,501 shares. The stock had previously closed at $0.51.
Analysts Set New Price Targets
A number of analysts have issued reports on the company. Piper Sandler lowered their target price on Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a report on Wednesday, April 9th. Canaccord Genuity Group increased their price target on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th.
Read Our Latest Stock Analysis on Tilray
Tilray Stock Performance
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The company has a fifty day moving average of $0.71 and a two-hundred day moving average of $1.16. The firm has a market capitalization of $443.32 million, a price-to-earnings ratio of -1.58 and a beta of 1.88.
Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The company had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. As a group, equities research analysts predict that Tilray Inc will post -0.2 earnings per share for the current fiscal year.
Institutional Trading of Tilray
Hedge funds have recently bought and sold shares of the company. Lido Advisors LLC bought a new stake in Tilray during the fourth quarter worth about $28,000. Verdence Capital Advisors LLC bought a new stake in shares of Tilray during the fourth quarter valued at approximately $29,000. Dudley Capital Management LLC bought a new position in shares of Tilray during the 4th quarter valued at about $29,000. Ameritas Advisory Services LLC purchased a new stake in shares of Tilray during the 4th quarter worth approximately $32,000. Finally, Newman Dignan & Sheerar Inc. raised its position in Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after purchasing an additional 10,000 shares during the period. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Stories
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
